Anshul Life Sciences 
Dealstreet

SAM, AZB act on acquisition of Anshul Life Sciences by Barentz

Dutch company Barentz has acquired Anshul Life Sciences.

Bar & Bench

Barentz has made an acquisition of Anshul Life Sciences for an undisclosed amount.

Shardul Amarchand Mangaldas & Co advised Barentz on this acquisition deal.

The transaction team consisted of by Roopal Kulsrestha (Partner), Neelam Pathak (Partner), Meghna Nachappa (Partner), Aparna R (Associate), Sandra Anil Varkey (Associate), Pranav Bajaj (Associate) and Sidharth Chamarthy (Associate).

Roopal Kulsrestha, Neelam Pathak

AZB & Partners advised Anshul Life Sciences and its promoters on this transaction.

The deal team comprised Senior Partner Vaidhyanadhan Iyer, Partner Sneha Nagvekar, Associates Deepti Narayanan, Priyasha Goyal, Jay Singhee and Meghna Somani.

Barentz is a leading global specialty ingredients solutions provider. With this acquisition, Barentz establishes a leading life science distribution platform in India and reinforces its commitment to providing innovative solutions and technical expertise pan-India.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

ED v. Mamata Banerjee: Live Updates from Calcutta High Court

Delhi High Court raps NGO for filing repeated PILs against mosques, dargahs

Section 17A PC Act is old wine in a new bottle, protects corrupt public servants: Justice BV Nagarathna in split verdict

Delhi High Court restores ban on 2 FDCs for Type II Diabetes; says govt can ban drugs without proving harm

NLU Delhi wins NLIU-NHRC Moot Court Competition 2026

SCROLL FOR NEXT